Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)

Overview of Financial Results

For the cumulative third quarter period ending March 2026, consolidated financial results recorded net sales of 48,632 million yen (1.1% increase YoY), operating income of 5,648 million yen (6.7% decrease YoY), ordinary income of 5,831 million yen (6.0% decrease YoY), and net income attributable to owners of parent of 3,396 million yen (14.8% decrease YoY). The semiconductor-related business saw a decrease in both sales and profits due to declining demand. The measurement and weighing instruments business offset weak demand in the US and South Korea through improved profitability of DSP devices, resulting in increased sales and operating income. The medical and healthcare equipment business experienced sales growth due to special demand in the Americas, but profits declined due to US tariffs and increased sales enhancement costs.

Financial Position and Dividend Status

Total assets amounted to 72,261 million yen (increase of 3,256 million yen YoY), net assets were 46,549 million yen (increase of 3,751 million yen YoY), and the equity ratio was 64.3% (up 2.4 points YoY). The dividend is planned at 50 yen per share annually (40 yen in the prior year), representing an increase from the previous year.

Full-Year Earnings Forecast

The consolidated full-year earnings forecast for the fiscal year ending March 2026 expects net sales of 70,000 million yen (4.3% increase YoY), operating income of 9,500 million yen (7.8% increase YoY), ordinary income of 9,400 million yen (5.0% increase YoY), net income attributable to owners of parent of 6,500 million yen (0.5% increase YoY), and earnings per share of 237.45 yen. There are no revisions from the most recent earnings guidance.